Stock Comparison

JNJ vs OSCR

Johnson & Johnson vs Oscar Health Inc

The Verdict

OSCR takes this one.

JNJ

Johnson & Johnson

1.0

out of 10

Distressed

Winner

OSCR

Oscar Health Inc

9.2

out of 10

Hidden Gem

Head-to-Head

N/A

Market Cap

$3.8B

N/A

P/E Ratio

0.0

N/A

Profit Margin

0.2%

N/A

Return on Equity

0.0%

N/A

Debt-to-Equity

0.0

Conservative

Overall Risk

Aggressive

1.0

DVR Score

9.2

The Deep Dive

JNJ1.0/10

Johnson & Johnson (JNJ) remains a fundamentally strong, diversified healthcare conglomerate with an impressive market capitalization. While possessing robust financials, wide economic moats, and consistent performance, its sheer size ($579.46B) fundamentally misaligns with the criteria for 10x growth within a 3-5 year timeframe. A 10x return would necessitate a market cap exceeding $5.7 trillion, ...

Full JNJ Analysis

OSCR9.2/10

Oscar Health Inc. continues to demonstrate strong momentum and validate its 10x growth potential. The most significant development since the last analysis is CEO Mark T. Bertolini's substantial $11.92 million share purchase, signaling high insider confidence and reinforcing the company's strategic direction. This, combined with favorable 2027 Medicare rate hikes and a subsequent 22% stock rally, b...

Full OSCR Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.